ST Pharm
ST Pharm
  • 01Who we are
  • 02Our record
  • 03Newsroom
  • 04Contact
    • En
    • Ko
ST Pharm
  • Science & Technology
    • Business Overview
    • CDMO
      • Small Molecule
      • Oligonucleotide
      • mRNA
    • CRO
      • AnaPath Research & Service
    • R&D
      • Virtual R&D
      • Global R&D
  • About
    • ST PHARM
    • Key Members
    • History
    • Global Approval
    • ST Pharm Family
    • CI
  • Public
    • PR (Public Relations)
      • News room
        • All
        • Media Focus
        • ST PHARM News
    • IR (Investor Relations)
      • Stock Information
      • IR Library
        • Disclosure Information
        • IR Materials
        • Notice
  • Careers
  • ESG
    • Overview
    • Environmental
    • Social
    • Governance
  • Sitemap
  • Contact
  • Linkedin
Public
Media Focus
  • PR (Public Relations)
    • News room
      • All
      • Media Focus
      • ST PHARM News
  • IR (Investor Relations)
    • Stock Information
    • IR Library
      • Disclosure Information
      • IR Materials
      • Notice

ST PHARM's Public Release

  • All
  • Media Focus
  • ST PHARM News
Media FocusST PHARM Cuts Joint Research Deal with Multiverse Pharma in the U.S.Feb 24, 2023
Media FocusST PHARM, signs $9.2million contract to supply MRI contrast medium raw materialsJan 11, 2023
Media FocusST PHARM, Top 10 CDMOs In APAC 2022Sep 26, 2022
Media FocusST PHARM Present Phase 1 Clinical Trial Results of HIV Treatment Candidate at AIDS 2022Aug 4, 2022
Media FocusST PHARM Scores FDA's cGMP Certification (NAI) for Oligo PlantAug 2, 2022
Media FocusST PHARM's Banwol Campus 'Oligo Manufacturing Plants' cGMP Certified by USA FDAAug 1, 2022
Media FocusST PHARM's Cutting-edge Technology to Reduce the Cost of Promising DrugJul 28, 2022
Media FocusST PHARM to Supply Lipids to Biotech in North AmericaMay 4, 2022
Media FocusKorean drugmakers team up with CEPI to become global vaccine suppliersDec 27, 2021
Media FocusST Pharm receives presidential award for improving labor-management relationsDec 1, 2021
Media FocusKorea-based ST Pharm takes leap towards world's largest oligonucleotide CDMONov 30, 2021
Media FocusKorean companies eyeing mRNA vaccines to treat cancerAug 17, 2021
Media FocusKorea launches mRNA vaccine consortiumJun 29, 2021
1of2
HOMEPublicPR (Public Relations)News roomMedia Focus
  • Science & Technology
    • Business Overview
    • CDMO
      • Small Molecule
      • Oligonucleotide
      • mRNA
    • CRO
      • AnaPath Research & Service
    • R&D
      • Virtual R&D
      • Global R&D
  • About
    • ST PHARM
    • Key Members
    • History
    • Global Approval
    • ST Pharm Family
    • CI
  • Public
    • PR (Public Relations)
      • News room
        • All
        • Media Focus
        • ST PHARM News
    • IR (Investor Relations)
      • Stock Information
      • IR Library
        • Disclosure Information
        • IR Materials
        • Notice
  • Careers
  • ESG
    • Overview
    • Environmental
    • Social
    • Governance
  • Sitemap
  • Contact
  • Linkedin
© 2025 ST Pharm. All rights reserved.
  • Sitemap
  • Contact